scholarly journals Comparison of histological staining patterns between canine cutaneous mast cell tumours and the local lymph node as a prognostic indicator

2015 ◽  
pp. 519-519
Author(s):  
Charles Pittaway ◽  
Stacey Piotrowski ◽  
Antonio Giulano ◽  
Jane Dobson ◽  
Fernando Constantino-Casas
Author(s):  
Thiago Henrique M. Vargas ◽  
Camila N. Barra ◽  
Lidia H. Pulz ◽  
Greice C. Huete ◽  
Karine G. Cadrobbi ◽  
...  

AbstractMast cell tumour (MCT) is the most frequent skin neoplasm in dogs. These tumours are characterised by variable behaviour and clinical presentation that make prognosis an important and challenging task in the veterinary practice. Galectin-3 (Gal-3) is known to influence several biological processes that are important in the cancer context and has been described as a prognostic marker for several human cancers. The aim of the present work was to characterise Gal-3 immunolabelling in canine cutaneous MCTs and to investigate its value as a prognostic marker for the disease. Thirty-four random cases of canine cutaneous MCT that were surgically treated with wide margins were included in this study. Gal-3 expression was evaluated using immunohistochemistry and the results were compared with the expression of apoptosis-related proteins, Ki67 index, histopathological grades, mortality due to the disease and post-surgical survival. The majority of the MCTs (65.8%) were positive for Gal-3. Gal-3 immunolabelling was variable among the samples (2.7%–86.8% of the neoplastic cells). The protein was located in the cytoplasm or in the cytoplasm and the nucleus. Gal-3 positivity was correlated with BCL2 expression (P < 0.001; r = 0.604), but not with Ki67 and BAX. No significant differences were detected between histological grades or in the survival analysis. Gal-3 expression correlates with BCL2 expression in MCTs. Although an efficient marker for several human neoplasms, the results presented herein suggest that Gal-3 immunolabelling is not an independent prognostic indicator for this disease.


2002 ◽  
Vol 39 (4) ◽  
pp. 452-457 ◽  
Author(s):  
T. O. Johnson ◽  
F. Y. Schulman ◽  
T. P. Lipscomb ◽  
L. D. Yantis

Most feline cutaneous mast cell tumors (CMCT) are behaviorally benign; however, there is a subset of these tumors with marked pleomorphism (previously termed poorly differentiated) that have been reported to be more aggressive. In this study, pleomorphic CMCT from 15 cats were identified from surgical biopsy submissions, and follow-up clinical data were obtained for 14 of these cats. Pleomorphic CMCT were discrete dermal nodules composed of sheets of pleomorphic round cells. Tumors from all 15 cats contained markedly cytomegalic and karyomegalic cells; 9/15 tumors (60%) contained multinucleated tumor giant cells. Typical mast cell granules were easily identified in sections stained with hematoxylin and eosin and with metachromatic stains and based on ultrastructural evaluation in cytomegalic as well as smaller tumor cells, indicating that the tumors were not poorly differentiated. The mitotic rate was very low (<1 mitosis per 10 high-power fields [hpf]) in 14 of 15 tumors (93%). Affected cats were 6–19 years old (mean age = 11.5 years), and there was no breed or sex predilection. Two cats had local recurrence. The only cat that had a pleomorphic CMCT with a high mitotic rate (1–2 mitoses/hpf) subsequently developed numerous other dermal neoplasms and was euthanatized. In this study, the large majority of feline pleomorphic CMCT were behaviorally benign. Mitotic rate is likely an important prognostic indicator of CMCT behavior.


2009 ◽  
Vol 21 (6) ◽  
pp. 821-825 ◽  
Author(s):  
Ricardo Francisco De Strefezzi ◽  
José Guilherme Xavier ◽  
Silvia Regina Kleeb ◽  
José Luiz Catão-Dias

2006 ◽  
Vol 42 (6) ◽  
pp. 430-434 ◽  
Author(s):  
Valerie Jasmine Poirier ◽  
William M. Adams ◽  
Lisa J. Forrest ◽  
Eric M. Green ◽  
Richard R. Dubielzig ◽  
...  

Forty-five dogs with incompletely excised grade II mast cell tumors were treated with radiation using a cobalt 60 teletherapy unit (15 fractions of 3.2 Gy for a total of 48 Gy). Twenty-four of the dogs underwent prophylactic regional lymph node irradiation. Three (6.7%) dogs had tumor recurrence, two (4.4%) dogs developed metastasis, and 14 (31%) dogs developed a second cutaneous mast cell tumor. No difference in overall survival rate was observed between the dogs receiving and not receiving prophylactic irradiation of the regional lymph node.


Sign in / Sign up

Export Citation Format

Share Document